DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.74+0.10 (+15.41%)
Close on Nov 18, 2026Market cap $2.26MP/E –Yield –
DataMeds AI revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
DataMeds AI's revenue for the twelve months ending Sep 30, 2026 was $7.68M, down 77.5% year over year. For fiscal 2025 it was $23.34M, up 28.7% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.34M | +28.7% |
| FY2024 | Dec 31, 2024 | $18.13M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.67M | -11.4% |
| Q2 FY2026 | Jun 30, 2026 | $1.78M | -77.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.56M | -85.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.67M | -86.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.01M | -46.9% |
| Q2 FY2025 | Jun 30, 2025 | $7.79M | +17391.8% |
| Q1 FY2025 | Mar 31, 2025 | $10.86M | – |
| Q4 FY2024 | Dec 31, 2024 | $12.41M | – |
| Q3 FY2024 | Sep 30, 2024 | $5.67M | – |
| Q2 FY2024 | Jun 30, 2024 | $44.54K | – |
See a number that looks wrong?